Recent advances in understanding and managing myasthenia gravis [version 1; referees: 3 approved]
Autoimmune myasthenia gravis (MG) is a neuromuscular junction disorder marked clinically by fatigable muscle weakness and serologically by the presence of autoantibodies against acetylcholine receptors (AChRs), muscle-specific kinase (MuSK), or lipoprotein-related protein 4 (LPR4). Over the past few...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-10-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-1727/v1 |